Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 93351-93400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04704674
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
N/A
Active, not recruiting
396 participants
Started: Sep 30, 2021 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05073926
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
N/A
Recruiting
100 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05054140
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
PHASE2
Active, not recruiting
450 participants
Started: Sep 30, 2021 · Completed: Jan 7, 2025
1 condition
1 sponsor
73 locations
NCT04822246
Root Caries Excavation with Air Water/powder Prophylaxis Device for ART Restorations
NA
Active, not recruiting
62 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04068701
Real-time Sensorimotor Feedback for Injury Prevention in Males Assessed in Virtual Reality
NA
Not yet recruiting
380 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT04973683
AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer
PHASE1
Active, not recruiting
14 participants
Started: Sep 30, 2021 · Completed: Dec 15, 2025
2 conditions
1 sponsor
1 location
NCT04110639
Intraoperative Monitoring of Femoral Head Perfusion
NA
Enrolling by invitation
30 participants
Started: Sep 30, 2021 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05151718
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
N/A
Recruiting
370 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
2 conditions
6 sponsors
1 location
NCT05019976
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
NA
Active, not recruiting
30 participants
Started: Sep 30, 2021 · Completed: Dec 1, 2027
3 conditions
1 sponsor
1 location
NCT05243134
The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
N/A
Recruiting
1,000 participants
Started: Sep 30, 2021 · Completed: Dec 30, 2025
6 conditions
1 sponsor
1 location
NCT07127393
Adding Chondrus Crispus Seaweeds to a Meal: Effect on Sensory Perception, Physical Comfort, Satiety and Food Intake
NA
Recruiting
32 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT05039606
Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma
PHASE2
Not yet recruiting
164 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04245566
Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
PHASE3
Not yet recruiting
425 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
0 locations
NCT06031792
Radiographic Assessment of the Healing Pattern Associated With Periradicular Endodontic Microsurgery
NA
Recruiting
44 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
1 condition
2 sponsors
2 locations
NCT05003843
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
NA
Recruiting
290 participants
Started: Sep 30, 2021 · Completed: Feb 28, 2027
2 conditions
1 sponsor
42 locations
NCT05077124
Safe and Timely Antithrombotic Removal (STAR) Registry
N/A
Recruiting
1,000 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
4 conditions
1 sponsor
30 locations
NCT05010226
Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
N/A
Not yet recruiting
30 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
2 conditions
1 sponsor
0 locations
NCT05029895
A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
N/A
Recruiting
170 participants
Started: Sep 29, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
59 locations
NCT04736394
A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients
PHASE3
Recruiting
800 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06837766
Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients
N/A
Recruiting
40 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT04635228
Biodesign® Otologic Repair Graft
N/A
Active, not recruiting
87 participants
Started: Sep 29, 2021 · Completed: Oct 31, 2026
2 conditions
1 sponsor
5 locations
NCT05768126
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
PHASE4
Recruiting
100 participants
Started: Sep 29, 2021 · Completed: Jan 31, 2026
1 condition
4 sponsors
1 location
NCT04753879
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
PHASE2
Recruiting
38 participants
Started: Sep 29, 2021 · Completed: Dec 1, 2029
1 condition
2 sponsors
1 location
NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
PHASE1
Recruiting
345 participants
Started: Sep 29, 2021 · Completed: Feb 28, 2028
14 conditions
1 sponsor
17 locations
NCT06284213
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
N/A
Active, not recruiting
1,892 participants
Started: Sep 29, 2021 · Completed: Jul 31, 2027
2 conditions
18 sponsors
17 locations
NCT04278651
Early Antenatal Support for Iron Deficiency Anemia
PHASE4
Recruiting
80 participants
Started: Sep 29, 2021 · Completed: Dec 30, 2025
3 conditions
2 sponsors
1 location
NCT04816227
Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments
N/A
Recruiting
180 participants
Started: Sep 29, 2021 · Completed: Oct 30, 2027
1 condition
1 sponsor
1 location
NCT06308757
Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
NA
Recruiting
42 participants
Started: Sep 29, 2021 · Completed: Dec 12, 2026
4 conditions
1 sponsor
1 location
NCT05241106
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
PHASE2
Recruiting
15 participants
Started: Sep 29, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05061745
Neuromodulation for Dysphoria
NA
Recruiting
100 participants
Started: Sep 29, 2021 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT06196684
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
N/A
Active, not recruiting
30 participants
Started: Sep 29, 2021 · Completed: Oct 30, 2026
2 conditions
1 sponsor
1 location
NCT04983875
Mammography and Breast Arterial Calcification: an Information-Sharing Trial
NA
Recruiting
14,875 participants
Started: Sep 29, 2021 · Completed: Mar 31, 2026
2 conditions
2 sponsors
1 location
NCT04216342
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
PHASE1
Recruiting
64 participants
Started: Sep 29, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04951856
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
PHASE4
Recruiting
2,166 participants
Started: Sep 29, 2021 · Completed: Sep 29, 2027
2 conditions
3 sponsors
1 location
NCT04941274
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
PHASE1/PHASE2
Recruiting
86 participants
Started: Sep 29, 2021 · Completed: Jun 1, 2028
1 condition
1 sponsor
1 location
NCT04975919
Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE2
Active, not recruiting
20 participants
Started: Sep 29, 2021 · Completed: May 31, 2026
4 conditions
1 sponsor
1 location
NCT04940962
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
NA
Recruiting
45 participants
Started: Sep 29, 2021 · Completed: Sep 30, 2027
2 conditions
1 sponsor
1 location
NCT04997499
Adolescent Subcutaneous (SQ) Injection Video Validation
NA
Active, not recruiting
30 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT04895839
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NA
Recruiting
500 participants
Started: Sep 29, 2021 · Completed: Oct 1, 2025
1 condition
1 sponsor
7 locations
NCT05092100
Neural Mechanisms for Reducing Interference During Episodic Memory Formation
NA
Enrolling by invitation
737 participants
Started: Sep 29, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05043220
Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy
NA
Active, not recruiting
100 participants
Started: Sep 29, 2021 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT04908813
Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer
PHASE2
Active, not recruiting
150 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05133843
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis
NA
Recruiting
50 participants
Started: Sep 29, 2021 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT04617756
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
PHASE2
Recruiting
50 participants
Started: Sep 29, 2021 · Completed: Oct 1, 2026
2 conditions
10 sponsors
9 locations
NCT04124341
PCS in Severe Treatment Resistant Depression
NA
Recruiting
15 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT05059522
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
PHASE3
Active, not recruiting
68 participants
Started: Sep 29, 2021 · Completed: Sep 30, 2026
5 conditions
1 sponsor
68 locations
NCT05104645
Analysis of the Psychometric Properties of Kinematic Parameters of Locomotion Measured by Inertial Units. Validation in Healthy Volunteers and Stroke Patients
NA
Recruiting
60 participants
Started: Sep 29, 2021 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05063136
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
PHASE3
Recruiting
1,979 participants
Started: Sep 28, 2021 · Completed: Sep 30, 2028
1 condition
1 sponsor
1 location
NCT05828953
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
PHASE2/PHASE3
Recruiting
30 participants
Started: Sep 28, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04940286
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
PHASE2
Active, not recruiting
13 participants
Started: Sep 28, 2021 · Completed: Oct 30, 2027
6 conditions
1 sponsor
1 location
Previous
1
More pages
1865
1866
1867
1868
1869
1870
1871
More pages
2369
Next